2019
DOI: 10.1590/s0004-2803.201900000-42
View full text |Buy / Rent full text
Has erratum 2019-9
|
Sign up to set email alerts
|

Abstract: Liver and biliary tract diseases are common causes of morbidity and mortality worldwide. Invasive procedures are usually performed in those patients with hepatobiliary diseases for both diagnostic and therapeutic purposes. Defining proper indications and restraints of commonly used techniques is crucial for proper patient selection, maximizing positive results and limiting complications. In 2018, the Brazilian Society of Hepatology (SBH) in cooperation with the Brazilian Society of Interventional Radiology and… Show more

Help me understand this report
Editorial notices

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(181 citation statements)
references
References 188 publications
(181 reference statements)
0
2
0
Order By: Relevance
“…Management of patients with liver diseases has evolved dramatically in Brazil in the last decades with the incorporation of several evidence-based recommendations in routine clinical practice. Most of those recommendations, endorsed by the Brazilian Society of Hepatology, were published as position papers or guidelines in different issues of Archives of Gastroenterology (1)(2)(3)(4)(5)(6)(7)(8) .…”
mentioning
confidence: 99%
“…Management of patients with liver diseases has evolved dramatically in Brazil in the last decades with the incorporation of several evidence-based recommendations in routine clinical practice. Most of those recommendations, endorsed by the Brazilian Society of Hepatology, were published as position papers or guidelines in different issues of Archives of Gastroenterology (1)(2)(3)(4)(5)(6)(7)(8) .…”
mentioning
confidence: 99%
“…In fact, several modalities of transcatheter intra-arterial therapy have been shown to increase survival in such patients: transarterial embolization (TAE), which involves tumor embolization without the use of chemotherapy; transarterial chemoembolization (TACE), including conventional TACE (cTACE), which involves the use of an embolic agent plus a chemotherapeutic agent (doxorubicin or cisplatin) and drug-eluting bead TACE (DEB-TACE), which involves the use of microspheres loaded with a chemotherapeutic agent; and selective internal radiation therapy (SIRT, previously known as transarterial radioembolization), which involves the use of particles labeled with the beta-emitting radioisotope yttrium-90. All of those modalities are aimed at inducing tumor necrosis, based on the fact that the vascularization of an HCC is predominantly arterial (the embolic agents occlude the vessels, resulting in ischemia), whereas most of the liver parenchyma receives its blood supply from the portal vein ( 4 ) . The ischemic effect can be enhanced by intra-arterial chemotherapy or radiotherapy.…”
mentioning
confidence: 99%